Correspondence 0001178913-25-001025 from MediWound Ltd. (MDWD)
MediWound Ltd.
Date: March 25, 2025 · CIK: 0001593984 · Accession: 0001178913-25-001025
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285908
Letter
Via EDGAR Transmission Tim Buchmiller Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 MediWound Ltd. Registration Statement on Form F-3 Filed March 19, 2025 Registration No. 333-285908
Re:
Dear Mr. Buchmiller:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on March 27, 2025 at 4:00 p.m. Eastern Time or as soon thereafter as practicable, or at such later time as MediWound Ltd. (the “ Company ”) or its counsel may request via telephone call to the staff. Please contact Michael J. Rosenberg of Latham & Watkins LLP, counsel to the Company, at (212) 906-1829, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Sincerely yours,
MediWound Ltd.
Show Raw Text
CORRESP
1
filename1.htm
MediWound Ltd.
42 Hayarkon Street
Yavne 8122745, Israel
+972 (77) 971-4100
March 25, 2025
Via EDGAR Transmission
Tim Buchmiller
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
MediWound Ltd.
Registration Statement on Form F-3
Filed March 19, 2025
Registration No. 333-285908
Dear Mr. Buchmiller:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933,
as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on March 27, 2025 at 4:00 p.m. Eastern Time or as soon thereafter as practicable, or at such later
time as MediWound Ltd. (the “ Company ”) or its counsel may request via telephone call to the staff. Please contact Michael J. Rosenberg of Latham &
Watkins LLP, counsel to the Company, at (212) 906-1829, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Sincerely yours,
MediWound Ltd.
By:
/s/ Hani Luxenburg
Name: Hani Luxenburg
Title: Chief Financial Officer
cc: Yaron Meyer, MediWound Ltd.
Joshua Kiernan, Latham & Watkins LLP
Michael J. Rosenberg, Latham & Watkins LLP.